Skip to main content
Log in

Gene expression of thrombomodulin, TNF-α and NF-KB in coronary artery disease patients of Pakistan

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Thrombomodulin (THBD) is an endothelial surface glycoprotein receptor, having a pivotal role in maintaining laminar blood flow. It functions to protect endothelial integrity by exhibiting anti-coagulation and anti-inflammatory properties thereby playing a key role in cardiovascular disease (CVD) pathology. Cholesterol lowering drugs have shown to alter the anti-inflammatory effects of cytokines. Understanding the molecular aspects of THBD gene and its relation to inflammatory cytokines is important to identify new prognostic and therapeutic targets for the CVD treatments. The present study was conducted to measure the expression of THBD, TNF-α and NF-kB genes in coronary artery disease patients (CAD) in Pakistani population. Lipid profile and BMI was compared both on fifty CAD patients and fifty healthy individuals. Expression analysis for THBD, TNF-α and NF-kB was carried out using real time PCR. The effect of lipid lowering drugs on cardiometabolic risk variables especially gene expression was analyzed. Our results indicated that the difference in BMI was marginal; however LDL-cholesterol and triglycerides levels in CAD patients were significantly higher than healthy individuals. THBD gene was significantly up-regulated whereas TNF-α and NF-kB were significantly down regulated in CAD individuals. Further exploration revealed that these variations were accounted to the use of statins by the patients. The use of statins by CAD patients up-regulated the mRNA expression of THBD by down-regulation of inflammatory mediators. The enhanced expression of endothelial THBD in response to cholesterol lowering drugs establishes a novel pleiotropic target that can be of clinical significance in thromboembolic and inflammatory disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

Data will be provided on request.

References

  1. World Health Organization. WHO cardiovascular diseases. (2020) https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) Accessed 27 Aug 2020

  2. Miranda JJ, Barrientos-Gutiérrez T, Corvalan C, Hyder AA, Lazo-Porras M, Oni T, Wells JCK (2019) Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat Med 25:1667–1679. https://doi.org/10.1038/s41591-019-0644-7

    Article  CAS  PubMed  Google Scholar 

  3. Liaquat A, Javed Q (2018) Current trends of cardiovascular risk determinants in Pakistan. Cureus 10(10):e3409. https://doi.org/10.7759/cureus.3409

    Article  PubMed  PubMed Central  Google Scholar 

  4. Demeulenaerev M, Devreese K, Vanbelleghem H, De Zaeytijd J, Walle JV, Van Biesen W, Van Laecke S (2018) Thrombomodulin and endothelial dysfunction: a disease-modifier shared between malignant hypertension and atypical hemolytic uremic syndrome. Nephron 140:63–73. https://doi.org/10.1159/000490201

    Article  CAS  Google Scholar 

  5. Loghmani H, Conway EM (2018) Exploring traditional and nontraditional roles for thrombomodulin. Blood 132:148–158. https://doi.org/10.1182/blood-2017-12-768994

    Article  CAS  PubMed  Google Scholar 

  6. Khan KA, McMurray JL, Mohammed F, Bicknell R (2019) C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation. FEBS J 286:3299–3332. https://doi.org/10.1111/febs.14985

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Giri H, Cai X, Panicker SR, Biswas I, Rezaie AR (2019) Thrombomodulin regulation of mitogen-activated protein kinases. Int J Mol Sci 20:1851. https://doi.org/10.3390/ijms20081851

    Article  CAS  PubMed Central  Google Scholar 

  8. Fiordelisi A, Iaccarino G, Morisco C, Coscioni E, Sorriento D (2019) NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases. Int J Mol Sci 20:1599. https://doi.org/10.3390/ijms20071599

    Article  CAS  PubMed Central  Google Scholar 

  9. Martin FA, Murphy RP, Cummins PM (2013) Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am J Physiol Heart Circ Physiol 304:H1585–1597. https://doi.org/10.1152/ajpheart.00096.2013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sepehri Z, Masoumi M, Ebrahimi N, Kiani Z, Nasiri AA, Kohan F, Fathollahi MS, Arababadi MK, Asadikaram G (2016) Atorvastatin, losartan and captopril lead to upregulation of TGF-β, and downregulation of IL-6 in coronary artery disease and hypertension. PLoS ONE 11(e0168312):2016. https://doi.org/10.1371/journal.pone.0168312.eCollection

    Article  Google Scholar 

  11. Pathak R, Ghosh SP, Zhou D, Hauer-Jensen M (2016) The Vitamin E analog gamma-tocotrienol (GT3) and statins synergistically up-regulate endothelial thrombomodulin (TM). Int J Mol Sci 17:1937. https://doi.org/10.3390/ijms17111937

    Article  CAS  PubMed Central  Google Scholar 

  12. Baysal SS, Koç Ş, Güneş A, Altiparmak IH (2018) Endothelium biomarkers endocan and thrombomodulin levels in isolated coronary artery ectasia. Eur Rev Med Pharmacol Sci 22:4677–4682. https://doi.org/10.26355/eurrev_201807_15528

    Article  CAS  PubMed  Google Scholar 

  13. Martin FA, McLoughlin A, Rochfort KD, Davenport C, Murphy RP, Cummins PM (2014) Regulation of thrombomodulin expression and release in human aortic endothelial cells by cyclic strain. PLoS ONE 9(9):e108254. https://doi.org/10.1371/journal.pone.0108254

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C T method. Nat Protoc 3:1101–1108. https://doi.org/10.1038/nprot.2008.73

    Article  CAS  PubMed  Google Scholar 

  15. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262

    Article  CAS  PubMed  Google Scholar 

  16. La Mura V, Tripodi A, Tosetti G, Cavallaro F, Chantarangkul V, Colombo M, Primignani M (2016) Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis. Liver Int 36:1322–1330. https://doi.org/10.1111/liv.13087

    Article  CAS  PubMed  Google Scholar 

  17. Daly C, Qian X, Castanaro C, Pasnikowski E, Jiang X, Thomson BR, Quaggin SE, Papadopoulos N, Wei Y, Rudge JS, Thurston G (2018) Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor. Sci Rep 8:505. https://doi.org/10.1038/s41598-017-18912-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Liu D, Yang G, Zhao X, Yang H (2018) Effects of probucol on atherosclerotic plaque and soluble thrombomodulin in patients with coronary heart disease. Exp Ther Med 16:886–890. https://doi.org/10.3892/etm.2018.6264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bongoni AK, Klymiuk N, Wolf E, Ayares D, Rieben R, Cowan PJ (2016) Transgenic expression of human thrombomodulin inhibits HMGB1-induced porcine aortic endothelial cell activation. Transplantation 100:1871–1879. https://doi.org/10.1097/TP.0000000000001188

    Article  CAS  PubMed  Google Scholar 

  20. Conway EM (2012) Thrombomodulin and its role in inflammation. Semin Immunopathol 34:107–125. https://doi.org/10.1007/s00281-011-0282-8

    Article  CAS  PubMed  Google Scholar 

  21. Nan B, Lin P, Lumsden AB, Yao Q, Chen C (2005) Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb Res 115:417–426. https://doi.org/10.1016/j.thromres.2004.10.010

    Article  CAS  PubMed  Google Scholar 

  22. Calder PC, Bosco N, Bourdet-Sicard R, Capuron L, Delzenne N, Dore J, Franceschi C, Lehtinen MJ, Recker T, Salvioli S, Visioli F (2017) Health relevance of the modification of low grade inflammation in ageing (inflammageing) and the role of nutrition. Ageing Res Rev 40:95–119. https://doi.org/10.1016/j.arr.2017.09.001

    Article  CAS  PubMed  Google Scholar 

  23. Mansoori B, Mohammadi A, Shirjang S, Baradaran B (2017) MicroRNAs in the diagnosis and treatment of cancer. Immunol Invest 46:880–897. https://doi.org/10.1080/08820139.2017.1377407

    Article  CAS  PubMed  Google Scholar 

  24. Nasef NA, Mehta S, Ferguson LR (2017) Susceptibility to chronic inflammation: an update. Arch Toxicol 91:1131–1341. https://doi.org/10.1007/s00204-016-1914-5

    Article  CAS  PubMed  Google Scholar 

  25. Yang X, Li L, Liu J, Lv B, Chen F (2016) Extracellular histones induce tissue factor expression in vascular endothelial cells via TLR and activation of NF-κB and AP-1. Thromb Res 137:211–218. https://doi.org/10.1016/j.thromres.2015.10.012

    Article  CAS  PubMed  Google Scholar 

  26. Pirazzi C, Håkansson L, Gustafsson C, Omerovic E, Wiklund O, Mancina RM (2019) High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease. Appl Clin Genet 12(71):2019. https://doi.org/10.2147/TACG.S202942.eCollection

    Article  Google Scholar 

  27. Coto E, Reguero JR, Avanzas P, Pascual I, Martín M, Hevia S, Morís C, Díaz-Molina B, Lambert JL, Alonso B, Cuesta-LLavona E (2019) Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease. Immunol let 208:39–43. https://doi.org/10.1016/j.imlet.2019.02.007

    Article  CAS  Google Scholar 

  28. Porreca E, Di Febbo C, Fusco L, Moretta V, Di Nisio M, Cuccurullo F (2004) Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese women. Atherosclerosis 172:175–180. https://doi.org/10.1016/j.atherosclerosis.2003.09.022

    Article  CAS  PubMed  Google Scholar 

  29. Zhou Q, Liao JK (2010) Pleiotropic effects of statins: basic research and clinical perspectives. Circ J 74:818–826. https://doi.org/10.1253/circj.cj-10-0110

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Masamura K, Oida K, Kanehara H, Suzuki J, Horie S, Ishii H, Miyamori I (2003) Pitavastatin-induced thrombomodulin expression by endothelial cells acts via inhibition of small G proteins of the Rho family. Arterioscler Thromb Vasc Biol 23:512–517. https://doi.org/10.1161/01.ATV.0000060461.64771.F0

    Article  CAS  PubMed  Google Scholar 

  31. Shi J, Wang J, Zheng H, Ling W, Joseph J, Li D, Mehta JL, Ponnappan U, Lin P, Fink LM, Hauer-Jensen M (2003) Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor α-induced thrombomodulin downregulation, blood coagul. Fibrinolysis 14:575–585. https://doi.org/10.1097/00001721-200309000-00010

    Article  CAS  Google Scholar 

  32. Fu Q, Wang J, Boerma M, Berbee M, Qiu X, Fink LM, Hauer-Jensen M (2008) Involvement of heat shock factor 1 in statin-induced transcriptional upregulation of endothelial thrombomodulin. Circ Res 103:367–377. https://doi.org/10.1161/CIRCRESAHA.108.174607

    Article  CAS  Google Scholar 

  33. Undas A, Brummel-Ziedins KE, Mann KG (2014) Anticoagulant effects of statins and their clinical implications. Thromb Haemost 111:392–400. https://doi.org/10.1160/TH13-08-0720

    Article  CAS  PubMed  Google Scholar 

  34. Rossi J, Rouleau L, Tardif JC, Leask RL (2010) Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress. Life Sci 87:92–99. https://doi.org/10.1016/j.lfs.2010.05.008

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by COMSATS University Islamabad and Shifa Tameer-e-Millat University, Islamabad.

Author information

Authors and Affiliations

Authors

Contributions

MR. was involved in Conceptualization, Methodology, Investigation, Formal analysis, Writing—Original Draft. AL. contributed in Conceptualization, Validation, Resources, Writing—Review & Editing, Project administration, Funding acquisition, Supervision. NS. and GUS. contributed through Resources, Investigation and Visualization. SM was involved in Conceptualization, Methodology and Investigation. MJK contributed in Conceptualization, Validation, Resources, Formal analysis, Writing—Review & Editing, Project administration, Funding acquisition, Supervision.

Corresponding authors

Correspondence to Afrose Liaquat or Muhammad Jawad Khan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study has been approved by the institutional and ethical review board of Shifa Tameer-e-Millat University (IRB # 016–506-2019) and COMSATS University Islamabad. The present study was approved by Ethics and IRB committee.

Informed consent

Written informed consent was taken from all the participants. Consent for publication was taken from all the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rafiq, M., Liaquat, A., Saeed, N. et al. Gene expression of thrombomodulin, TNF-α and NF-KB in coronary artery disease patients of Pakistan. Mol Biol Rep 47, 7575–7582 (2020). https://doi.org/10.1007/s11033-020-05824-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-020-05824-6

Keywords

Navigation